ACD-A
ACD-A (032922700)
Approved
Approval ID
bee8e967-496c-4541-b092-ead6c8c80269
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Nov 1, 2022
Manufacturers
FDA
Fenwal, Inc.
DUNS: 794519020
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Antiocoagulant Citrate Dextrose Solution, Formula A
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code0942-9005
Application NumberBN160918
Product Classification
M
Marketing Category
C73594
G
Generic Name
Antiocoagulant Citrate Dextrose Solution, Formula A
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateNovember 1, 2022
FDA Product Classification
INGREDIENTS (3)
DEXTROSE MONOHYDRATEActive
Quantity: 2.45 g in 100 mL
Code: LX22YL083G
Classification: ACTIB
ANHYDROUS CITRIC ACIDActive
Quantity: 730 mg in 100 mL
Code: XF417D3PSL
Classification: ACTIB
SODIUM CITRATE, UNSPECIFIED FORMActive
Quantity: 2.2 g in 100 mL
Code: 1Q73Q2JULR
Classification: ACTIB